Warning

Definition

Eosinophilia is defined as an elevation of the eosinophil count above 0.4 x109/L. The initial step in the evaluation of eosinophilia is to rule out reactive (secondary) causes.

The most common causes of eosinophilia are allergy, eczema/asthma, drug-induced and parasitic infections.

After reactive causes have been ruled out, the patient may be referred to Haematology for investigation of clonal eosinophilia.

Who to refer, who not to refer, how to refer

Who to refer:

Patients with significant persistent eosinophilia (≥ 1.5 x 109/L) without obvious underlying reactive cause.

Who not to refer:

  • Reactive eosinophilia – the patient may require assessment by other specialties, e.g. Rheumatology, Dermatology, Infectious Disease, Respiratory Medicine depending on symptoms
  • Patients with persistent unexplained mild to moderate eosinophilia (0.4-1.4 x109/L) can be given a diagnosis of idiopathic eosinophilia once secondary causes have been excluded.

Please see Primary Care Management for initial investigative approaches.

How to refer:

SCI Gateway to the Department of Haematology BGH 

Primary care management

Primary care investigations

  • Look for underlying causes such as
    • Allergic disorders such as atopic eczema, asthma, hay fever
    • Drugs
    • Parasites
    • Vasculitis (e.g. eosinophilic granulomatosis with polyangiitis)
    • Allergic bronchopulmonary aspergillosis
    • Malignancy
    • Hodgkin lymphoma.

Investigations:

  • FBC + film
  • CRP
  • U&E, LFT, LDH
  • Stools x 3 for ova, cysts and parasites
  • Repeat FBC at 3 months.

Editorial Information

Last reviewed: 17/01/2025

Next review date: 17/01/2027

Author(s): Charlotte Robertson.